Inventor · disambiguated record
Michael J. Burke
Also filed as: BURKE MICHAEL · BURKE MICHAEL J · BURKE MICHAEL JASON
28 granted patents·18 pending applications·79 citations·filing 2002–2024
95Inventor score
Files withBOEHRINGER INGELHEIM INT16BAYER PHARMACEUTICALS CORP6IKENA ONCOLOGY INC6BLUEPRINT MEDICINES CORP4ABEYWARDANE ASITHA3
Top patents by PatentIndex Score
46 records- 0194US11534441B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 27, 2022·3 cites·25 claims
- 0290US12042495B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 0388US10364255B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jul 30, 2019·6 cites·39 claims
- 0488US7622594B2Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Nov 24, 2009·16 cites·8 claims
- 0587US10875852B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 29, 2020·2 cites·12 claims
- 0687US8551982B2Benzodioxane inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2012·Granted Oct 8, 2013·11 cites·42 claims
- 0786US9975882B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 22, 2018·5 cites·40 claims
- 0883US9133146B2Benzodioxane inhibitors of leukotriene productionBOEHRINGER INGELHEIM INT·Filed 2013·Granted Sep 15, 2015·6 cites·5 claims
- 0982US10138229B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·2 cites·20 claims
- 1080US8946203B2Benzodioxane inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Feb 3, 2015·6 cites·16 claims
- 1180US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 1280US2025011315A1Aryl hydrocarbon receptor (ahr) agonists and uses thereofIKENA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 1379US7384947B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2006·Granted Jun 10, 2008·2 cites·5 claims
- 1478US8658637B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofKUZMICH DANIEL·Filed 2007·Granted Feb 25, 2014·4 cites·4 claims
- 1577US12030876B2Aryl hydrocarbon receptor (AHR) agonists and uses thereofIKENA ONCOLOGY INC·Filed 2023·Granted Jul 9, 2024·0 cites·23 claims
- 1672US12459895B2MEK inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 1770US7144885B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Dec 5, 2006·4 cites·26 claims
- 1869US11608329B2Aryl hydrocarbon receptor (AHR) agonists and uses thereofIKENA ONCOLOGY INC·Filed 2020·Granted Mar 21, 2023·0 cites·20 claims
- 1969US10570118B2Isoquinolones as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Feb 25, 2020·1 cites·12 claims
- 2069US2021009567A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2168US11878958B2MEK inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2023·Granted Jan 23, 2024·0 cites·22 claims
- 2267US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 2367US6780859B2Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Aug 24, 2004·3 cites·16 claims
- 2465US2020055843A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2563US2019092759A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2662US2018222893A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2760US2014045813A1Heteroaromatic compounds as btk inhibitorsBENTZIEN JOERG MARTIN·Filed 2013·Application pending·0 cites
- 2860US2024336630A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 2960US2018030037A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 3059US2009143412A1Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2008·Application pending·0 cites
- 3159US2017320867A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 3259US2024199648A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 3354US2016031872A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3453US2019263828A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3552US7429584B2Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 30, 2008·0 cites·10 claims
- 3652US2021300912A1Aryl hydrocarbon receptor (ahr) agonists and uses thereofIKENA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 3752US2024261288A1Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancerLKENA ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 3846US8268859B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofHARCKEN CHRISTIAN·Filed 2009·Granted Sep 18, 2012·0 cites·12 claims
- 3944US9533999B2Fused thiazin-3-ones as KCA3.1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2013·Granted Jan 3, 2017·0 cites·28 claims
- 4043US8895750B2Heteroaromatic compounds as BTK inhibitorsBOSANAC TODD·Filed 2014·Granted Nov 25, 2014·0 cites·16 claims
- 4143US2006004011A1Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2003·Application pending·0 cites
- 4242US9403830B2Inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Aug 2, 2016·0 cites·15 claims
- 4340US2004236110A1Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4437US2004267017A13-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4535US9828364B2Pyrazole compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Nov 28, 2017·0 cites·7 claims
- 4634US8729114B2Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-SBURKE MICHAEL J·Filed 2011·Granted May 20, 2014·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Michael J. Burke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →